To the Editor: In his Clinical Crossroads article, Dr Brust1 discussed the patient Mr E, an older, moderate to heavy alcohol drinker experiencing memory difficulty and an apparently unrelated polyneuropathy. Mild cognitive impairment (MCI), early Alzheimer disease (AD), Wernicke-Korsakoff syndrome, and “alcoholic dementia” were considered as possible diagnoses. Appropriate management of the suggested diagnosis of MCI or early AD for this patient included measures to reduce alcohol dependence and to delay progression of the cognitive impairment. However, many epidemiological studies have failed to identify a positive relationship between moderate alcohol intake (usually up to 1 or 2 drinks daily) and risk of dementia, and they have also found such amounts to be protective.2 - 3
We evaluated the association of alcohol consumption and the incidence of MCI in 1445 non–cognitively impaired individuals and on its progression to dementia in 121 patients with MCI aged 65 to 84 years participating in the Italian Longitudinal Study on Aging, with a 3.5-year follow-up.3 Patients with MCI who consumed up to 1 drink per day had a lower rate of progression to dementia in comparison with patients with MCI who never consumed alcohol. Overall, compared with nondrinkers, patients with MCI who consumed 1.0 to 14.9 g of alcohol per day derived mostly from wine had an 85% lower rate of progression to dementia. No significant associations were found between any levels of drinking and the incidence of MCI in non–cognitively impaired individuals vs abstainers. To the best of our knowledge, only 2 other studies have examined the association of alcohol consumption and the risk of MCI.4 - 5
It is possible that moderate lifestyles in general, which will vary according to different cultural environments, protect from cognitive impairment. Thus, it may not be the direct effect of alcohol or specific substances in alcoholic drinks that might provide protection, but moderate alcohol drinking may be an indicator of a complex set of favorable social and lifestyle factors. A protective effect of alcohol on cognitive function in moderate drinkers could be due to a relatively poor health status among abstainers or because cognitive status influences alcohol consumption and overall health status.
Among management options, Dr Brust included total abstinence from alcohol, but given the observational evidence that moderate alcohol intake may be linked to a protective effect against MCI and dementia,2 - 4 the uncertain role of alcohol in contributing to either polyneuropathy or cognitive impairment, and the challenge in achieving total abstinence, a viable alternative option for this patient could also be moderate drinking (1.0 to 14.9 g of alcohol per day).
Financial Disclosures: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 6
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.